The Zacks Analyst Blog SFYX, CNCR, FXN and DIV
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 11 2024
0mins
Source: NASDAQ.COM
Featured ETFs: Zacks.com highlights several low-priced ETFs, including SoFi Next 500 ETF, Range Cancer Therapeutics ETF, First Trust Energy AlphaDEX Fund, and Global X SuperDividend U.S. ETF, which are appealing for investors seeking affordability and potential for significant gains.
Investment Considerations: While low-priced stocks and ETFs offer opportunities for diversification and liquidity, they also come with higher volatility risks and potential for price manipulation, making thorough research essential before investing.
Analyst Views on FXN
Wall Street analysts forecast FXN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FXN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 17.600
Low
Averages
High
Current: 17.600
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
